Sterile keratitis after uneventful corneal collagen cross-linking in a patient with Axenfeld-Rieger syndrome

Int Ophthalmol. 2019 May;39(5):1169-1173. doi: 10.1007/s10792-018-0907-1. Epub 2018 Mar 28.

Abstract

Purpose: To report on a keratoconus (KC) patient with Axenfeld-Rieger syndrome (ARS) who developed sterile keratitis after accelerated corneal collagen cross-linking (CXL).

Methods: An 18-year-old patient with ARS and KC who had previously undergone intrastromal ring segment implantation underwent accelerated CXL (9 mW/cm2 UVA intensity for 10 min).

Results: After uneventful surgery, the patient presented with severe photophobia, redness of the eye, and decreased vision 72 h following the procedure. Slit-lamp examination showed anterior multiple superficial stromal infiltrates in the central cornea with an overlying epithelium defect. Due to the lack of pain and absence of any pathogen from corneal samples, a diagnosis of sterile keratitis was considered. A combination of topical antibiotic and corticosteroid regimen was administered. Three months after CXL slit-lamp examination showed a mild stromal scar overlying the central cornea, which did not decrease visual acuity.

Conclusions: The mechanism by which the sterile keratitis occurs following CXL remains unclear. For our case, the reason of post-CXL sterile keratitis could be considered as an immune response due to the staphylococcal antigens. Furthermore, the possible developmental disturbance of corneal stroma in ARS might have contributed to the development of post-CXL sterile keratitis.

Keywords: Axenfeld-Rieger syndrome; Corneal collagen cross-linking; Keratoconus; Sterile keratitis.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Anterior Eye Segment / abnormalities*
  • Collagen / adverse effects*
  • Collagen / therapeutic use
  • Corneal Stroma / pathology
  • Corneal Topography
  • Cross-Linking Reagents / adverse effects*
  • Cross-Linking Reagents / therapeutic use
  • Eye Abnormalities / complications*
  • Eye Diseases, Hereditary / complications*
  • Humans
  • Keratitis / chemically induced*
  • Keratitis / diagnosis
  • Keratoconus / complications
  • Keratoconus / drug therapy*
  • Male
  • Photochemotherapy / adverse effects*
  • Photosensitizing Agents / therapeutic use
  • Riboflavin / adverse effects*
  • Riboflavin / therapeutic use
  • Ultraviolet Rays
  • Visual Acuity

Substances

  • Cross-Linking Reagents
  • Photosensitizing Agents
  • Collagen
  • Riboflavin

Supplementary concepts

  • Axenfeld-Rieger syndrome